title: [Enhancing efficacy of the primary antibacterial therapy for intraabdominal infections].
abstract: The positive experience of their own for combined application of Hepacef and Ornizol preparations (manufactured by firm ARTERI-UM, Ukraine) as an empirical antibacterial therapy for intraabdominal infections was summarized. The preparations efficacy, the disease outcome and possible recommendations for their application in the intraabdominal infection treatment were estimated.
authors.forename: V V
authors.initials: VV
authors.lastname: Boĭko
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Ivanova
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D013505:Digestive System Surgical Procedures; D004359:Drug Therapy, Combination; D005260:Female; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000254:growth & development; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006094:Gram-Positive Bacteria / Q000187:drug effects / Q000254:growth & development; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D059413:Intraabdominal Infections / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009593:Nitroimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D010529:Peritoneal Cavity / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D014455:Ukraine
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D009593:Nitroimidazoles